HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Triggering apoptosis in cancer cells with an analogue of cribrostatin 6 that elevates intracellular ROS.

Abstract
Elevation of reactive oxygen species (ROS) is both a consequence and driver of the upregulated metabolism and proliferation of transformed cells. The resulting increase in oxidative stress is postulated to saturate the cellular antioxidant machinery, leaving cancer cells susceptible to agents that further elevate their intracellular oxidative stress. Several small molecules, including the marine natural product cribrostatin 6, have been demonstrated to trigger apoptosis in cancer cells by increasing intracellular ROS. Here, we report the modular synthesis of a series of cribrostatin 6 derivatives, and assessment of their activity in a number of cell lines. We establish that placing a phenyl ring on carbon 8 of cribrostatin 6 leads to increased potency, and observe a window of selectivity towards cancer cells. The mechanism of activity of this more potent analogue is assessed and demonstrated to induce apoptosis in cancer cells by increasing ROS. Our results demonstrate the potential for targeting tumors with molecules that enhance intracellular oxidative stress.
AuthorsD J Asby, M G Radigois, D C Wilson, F Cuda, C L L Chai, A Chen, A S Bienemann, M E Light, D C Harrowven, A Tavassoli
JournalOrganic & biomolecular chemistry (Org Biomol Chem) Vol. 14 Issue 39 Pg. 9322-9330 (Oct 04 2016) ISSN: 1477-0539 [Electronic] England
PMID27722456 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Isoquinolines
  • Reactive Oxygen Species
  • cribrostatin 6
Topics
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Apoptosis (drug effects)
  • Cell Line, Tumor
  • Drug Screening Assays, Antitumor (methods)
  • Humans
  • Inhibitory Concentration 50
  • Isoquinolines (chemistry, pharmacology)
  • MCF-7 Cells
  • Reactive Oxygen Species (metabolism)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: